DNA Chip Research Inc. (2397.T)

JPY 1091.0

(0.0%)

EBITDA Summary of DNA Chip Research Inc.

  • DNA Chip Research Inc.'s latest annual EBITDA in 2023 was -217 Million JPY , up 38.24% from previous year.
  • DNA Chip Research Inc.'s latest quarterly EBITDA in 2024 Q1 was -9.75 Million JPY , up 55.83% from previous quarter.
  • DNA Chip Research Inc. reported an annual EBITDA of -345.07 Million JPY in 2022, down -124.3% from previous year.
  • DNA Chip Research Inc. reported an annual EBITDA of -151 Million JPY in 2021, down -2.57% from previous year.
  • DNA Chip Research Inc. reported a quarterly EBITDA of -64.74 Million JPY for 2023 Q2, up 32.23% from previous quarter.
  • DNA Chip Research Inc. reported a quarterly EBITDA of -22.07 Million JPY for 2023 Q4, up 70.71% from previous quarter.

Annual EBITDA Chart of DNA Chip Research Inc. (2023 - 2019)

Historical Annual EBITDA of DNA Chip Research Inc. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 -217 Million JPY 38.24%
2022 -345.07 Million JPY -124.3%
2021 -151 Million JPY -2.57%
2020 -150.57 Million JPY -43.31%
2019 -106 Million JPY 0.0%

Peer EBITDA Comparison of DNA Chip Research Inc.

Name EBITDA EBITDA Difference
Shin Nippon Biomedical Laboratories, Ltd. 8.98 Billion JPY 102.416%
Cosmo Bio Company,Limited 669 Million JPY 132.436%
H.U. Group Holdings, Inc. 13.64 Billion JPY 101.59%
FALCO HOLDINGS Co., Ltd. 3.13 Billion JPY 106.928%
BML, Inc. 16.41 Billion JPY 101.322%
Human Metabolome Technologies, Inc. 306.48 Million JPY 170.803%
Precision System Science Co., Ltd. -661.75 Million JPY 67.208%